FDA Panel Unanimously Backs Cannabis Drug for Severe Epilepsy

Even though Epidiolex is derived from marijuana (Cannabis sativa), it does not have properties conducive to abuse, said the FDA reviewers. That is crucial, because currently, Epidiolex is considered to be a Schedule I drug by the Drug Enforcement Administration (DEA). If the FDA approves Epidiolex, ...

read more here
Delivered by @can_nab_is